NCCN Annual Conference Returns In-Person for 2023; New Cancer Research Findings, NCCN Guidelines Updates, Plus Best Practices for Meeting Today’s Challenges in Oncology Live in Orlando and also Streaming Online

MEDIA ADVISORY

What:  The National Comprehensive Cancer Network^® (NCCN^®) is hosting the NCCN 2023 Annual Conference—live in Orlando and with a concurrent virtual option. The three-day oncology conference will include:

• Clinical Updates in Oncology and Best Practices in Oncology Sessions: presenting new and emerging therapies for managing multiple cancer types, as well as for supportive care including pain management, sexual health, screening recommendations, and more. Advances and remaining controversies will be discussed and contextualized. Plus, best practices for interprofessional oncology care teams and administrative staff to enhance patient care and meet the needs of patients across a changing health care landscape.
• Plenary Sessions: addressing important and timely issues affecting the delivery of cancer care, such as patient sexual orientation and gender identity, staffing shortages, and the mental health impact of cancer treatment.
• Challenging Case Reviews and Case-Based Presentations: providing opportunities for interactive discussion of cases to reinforce knowledge and develop strategies for the management of a variety of cancers.
• More than 150 Abstract Poster Presentations featuring original research data in a variety of oncology-related categories.
• An Interactive Exhibit Hall.
• Additional Opportunities for In-Person Attendees to Network and Continue the Conversation with Experts

When: Friday, March 31 – Sunday, April 2, 2022

Where: New Live Location

Orlando World Center Marriott

8701 World Center Drive

Orlando, FL 32821

*Virtual attendance is also available via NCCN’s user-friendly online platform*

Featuring:

• Plenary Session: Health System Recruitment and Retention Strategies | Friday, March 31 | 10:45 am – 12:00 pm EDT​
  • Moderator: Timothy Kubal, MD, MBA, Moffitt Cancer Center
  • Panelists:
    • Rebecca L. Caires, MBA, Robert H. Lurie Comprehensive Cancer Center of Northwestern University
    • Anne H. Gross, PhD, RN, NEA-BC, FAAN, Dana-Farber Cancer Institute
    • Todd A. Pickard, MMSc, PA-C, University of Texas MD Anderson Cancer Center
    • Kristi Stiffler, MPH, Fred Hutchinson Cancer Center

• Plenary Session: Best Practices for Addressing the Health Needs of the LGBTQ+ Community in Oncology Care | Saturday, April 1 | 10:45 am – 12:00 pm EDT​
  • Moderator: Clifford Goodman, PhD, The Lewin Group
  • Panelists:
    • Bláz Bush, MEd, Stanford Medicine LGBTQ+ Health Program
    • Paula Chambers Raney, Fight Colorectal Cancer
    • Shail Maingi, MD, Dana-Farber Cancer Institute
    • Mandi L. Pratt-Chapman, PhD, GW Cancer Center
    • Scout, PhD, National LGBT Cancer Network

• Plenary Session: Sleep Disorder, Fatigue, and Cognitive Function in Cancer Survivors | Sunday, April 2 | 11:35 am – 12:35 pm EDT
  • Moderator: Andrew T. Day, MD, MPH, UT Southwestern Simmons Comprehensive Cancer Center
  • Presenters:
    • Kristin Dickinson, PhD, RN, Fred & Pamela Buffett Cancer Center
    • Halle C. F. Moore, MD, Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
    • Eric Zhou, PhD, Dana-Farber Cancer Institute

Additional Sessions Include the Following Topics:

• Adult Patients with Glioma
• Advanced Ovarian and Related Cancers
• Bladder Cancer
• Breast Cancer (including Metastatic)
• Cancer Screening in Underrepresented Populations
• Central Nervous System Cancers
• Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
• Clear and Non-Clear Cell Renal Cell Carcinoma
• Hepatobiliary Cancers
• Hereditary/Familial Ovarian Cancer
• Immunotherapy-Related Toxicities
• Lung Cancer Screening
• Metastatic Brain Tumors
• Metastatic Cervical Cancer
• Metastatic Colorectal Cancer
• Metastatic Esophageal Squamous Cell Carcinoma
• Metastatic Prostate Cancer
• Mobile Screening Programs
• Neoadjuvant Treatment Approaches for Stage II-III Rectal Cancer
• New Patient Access Programs
• Non-Small Cell Lung Cancer (including Metastatic)
• Pain Management for Patients with Cancer
• Patient Reported Outcomes
• Preventing Cancer-Associated Venous Thromboembolic Disease
• Reducing Hospital Admissions and Readmissions
• Relapsed/Refractory Multiple Myeloma
• Sexual Identity and Function in Patients with Cancer and Survivors
• Social Determinants of Health: Collection, Integration, and Intervention

Visit NCCN.org/conference for the full agenda and list of speakers. For a complimentary press pass, please contact Rachel Darwin: Darwin@NCCN.org or 267-622-6624.